Groove Botanicals Inc.

11/12/2026 | Press release | Distributed by Public on 11/12/2026 09:25

Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q contains predictions, estimates and other forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "intends," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology. Forward-looking statements involve known and unknown risks, uncertainties and other factors including the risks set forth in the section entitled "Risk Factors" in our registration statement on Form 10-12G/A, as filed with the Securities and Exchange Commission (the "SEC") on November 6, 2023, that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements.

Forward-looking statements represent our management's beliefs and assumptions only as of the date of this Report. You should read this Report with the understanding that our actual future results may be materially different from what we expect.

All forward-looking statements speak only as of the date on which they are made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they are made, except as required by federal securities and any other applicable law.

The management's discussion and analysis of our financial condition and results of operations are based upon our consolidated unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP").

The following discussion of our financial condition and results of operations should be read in conjunction with the notes to the consolidated unaudited financial statements appearing elsewhere in this Report and the Company's audited financial statements for the fiscal year ended March 31, 2026, as filed with the SEC in its Annual Report on Form 10-K, along with the accompanying notes. As used in this Quarterly Report, the terms "we," "us," "our" and the "Company" means Groove Botanicals, Inc.

The Company relies primarily on its current sole officer and director, Kent Rodriguez to manage its day-to-day business and has outsourced professional services to third parties in an effort to maintain lower operational costs. Effective June 30, 2026, Mr. Rodriguez's employment agreement was terminated and he continues to serve without salary, and the Company continues to pay his medical and dental insurance premiums.

Mr. Rodriguez, as the holder of the Company's issued and outstanding shares of the Company's Series A Preferred Stock, holds 51% of the voting rights of the Company. As a result, Mr. Rodriguez controls the outcome of all matters submitted to a vote of our stockholders, including the election of directors.

Plan of Operations

On September 14, 2023, we filed a registration statement on Form 10-12g which was deemed effective by the Securities and Exchange Commission ("SEC") on November 13, 2023. The Company intends to change our name from Groove Botanicals, Inc., to Nordmark Technologies, Inc., to better describe our corporate focus. There can be no assurance that the name change will be completed.

We are an early-stage company. We intend to identify and evaluate early-stage intellectual property and applied technologies that may originate from, or be developed within, the research ecosystems of Norwegian universities, university hospitals, applied research institutions, and related technology-transfer or innovation organizations, and to assess whether selected technologies may be suitable for licensing, further development, or commercialization in North America through licensing, strategic relationships, commercial partnerships, customer arrangements, or other commercial structures, if available. We have selected an initial geographic focus on Norway as we believe a concentrated review of a defined research ecosystem may allow us to evaluate opportunities more efficiently, including energy and offshore technology, maritime and ocean industries, aquaculture, carbon capture, health sciences, medical technology, and other applied industrial and digital technologies.

14

We do not currently have any products, technologies, or intellectual property rights. We have not entered into any licensing agreements or formal arrangements with any university, research institution, or technology transfer organization to date, and there can be no assurance that suitable technologies will be identified, licensed, developed, or successfully commercialized.

As the Company continues its business development and asset acquisitions, the Company anticipates our capital needs to be between $500,000 and $15,000,000 (varying based on growth strategies).

Results of Operations

Three Months Ended September 30, 2026, and September 30, 2025

Revenue

We have not generated any revenue since our inception and do not expect to generate any revenue from the sale of products in the near future.

Net Loss

We reported a net loss of $31,562 in the three months ended September 30, 2026 as compared to a loss of $32,383 in the three months ended September 30, 2025 and a net loss attributable to our common stockholders of $86,179 and $87,001, respectively, which includes accrued dividends on our Series A and B Preferred stock of $54,617 and $54,618 in the three months ended September 30, 2026 and 2025, respectively.

Three Months ended

September 30,

2026

2025

Net sales

$ - $ -

Operating expenses:

Selling, General and Administrative Expenses

8,092 18,018

Rent

3,600 3,600

Legal and Professional Expenses

21,070 10,765

Total operating expenses

32,762 32,383

Income (loss) from operations

(32,762 ) (32,383 )

Other income

$ 1,200 $ -

Total other income

$ 1,200 $ -

Net income (loss)

$ (31,562 ) $ (32,383 )

Dividends on Preferred Stock

(54,617 ) (54,618 )

Net (loss) attributable to common stockholders

$ (86,179 ) $ (87,001 )

Operating Expenses

Total operating expenses for the three months ended September 30, 2026 were $32,762 compared to $32,383 for the three months ended September 30, 2025. Selling, General and Administrative Expenses decreased from $18,018 to $8,092, primarily because no compensation was accrued to our Chief Executive Officer following the termination of his employment agreement effective June 30, 2026, compared to $12,000 accrued in the prior-year period. Legal and Professional Expenses increased from $10,765 to $21,070, reflecting $15,000 of legal fees for the preparation of an information statement on Schedule 14C, partially offset by lower filing fees, which were $6,484 in the prior-year period when the Company re-filed certain prior SEC reports. Rent remained constant at $3,600. In addition, the Company recorded Other income of $1,200 during the three months ended September 30, 2026 from the write-off of a prior-period accounts payable balance for rent, following confirmation from the landlord that no amount was owed, with no comparable item in the prior-year period.

15

Dividends on Preferred Stock

Dividends on Preferred Stock were $54,617 and $54,618 for the three months ended September 30, 2026 and 2025, respectively. These dividends on preferred stock are required subject to the designation of the preferred stock and contribute to the net loss attributable to our common stockholders.

Six Months Ended September 30, 2026, and September 30, 2025

Net Loss

We reported a net loss of $52,733 in the six months ended September 30, 2026 as compared to a loss of $70,553 in the six months ended September 30, 2025 and a net loss attributable to our common stockholders of $161,968 and $179,788, respectively, which includes accrued dividends on our Series A and B Preferred stock of $109,235 in each of the six months ended September 30, 2026 and 2025.

Six Months ended

September 30,

2026

2025

Net sales

$ - $ -

Operating expenses:

Selling, General and Administrative Expenses

26,811 36,983

Rent

7,200 7,200

Legal and Professional Expenses

27,069 26,370

Total operating expenses

61,080 70,553

Income (loss) from operations

(61,080 ) (70,553 )

Other income

$ 8,347 $ -

Total other income

$ 8,347 $ -

Net income (loss)

$ (52,733 ) $ (70,553 )

Dividends on Preferred Stock

(109,235 ) (109,235 )

Net (loss) attributable to common stockholders

$ (161,968 ) $ (179,788 )

Operating Expenses

Total operating expenses for the six months ended September 30, 2026 were $61,080 compared to $70,553 for the six months ended September 30, 2025. Selling, General and Administrative Expenses decreased from $36,983 to $26,811, primarily because compensation accrued to our Chief Executive Officer was $12,000 compared to $24,000 in the prior-year period. Legal and Professional Expenses increased from $26,370 to $27,069, as $15,000 of legal fees for the Schedule 14C information statement were largely offset by lower audit fees following the Company's change in independent registered public accounting firm in May 2026 and lower filing fees. Rent remained constant at $7,200. In addition, the Company recorded Other Income of $8,347 during the six months ended September 30, 2026, comprising a settlement of $7,147 received from the Company's former independent registered public accounting firm, BF Borgers CPA PC, and $1,200 from the write-off of a prior-period accounts payable balance for rent, with no comparable items in the prior-year period.

16

Dividends on Preferred Stock

Dividends on Preferred Stock were $109,235 for each of the six months ended September 30, 2026 and 2025.

Operating Activities

For the Six Months Ended

September 30,

2026

2025

Net Cash Used in Operating Activities

$ (50,636 ) (44,854 )

Net Cash From Investing Activities

- -

Net Cash From Financing Activities

51,000 44,304

Net Change in Cash

364 (550 )

Cash at End of Period

$ 1,866 $ 1,492

Net cash used by operating activities was $50,636 for the six months ended September 30, 2026, compared to $44,854 for the six months ended September 30, 2025.

Net cash used in operating activities for the six months ended September 30, 2026, was primarily the result of a net loss of $52,733, an increase in prepaid expenses of $13,770 and a decrease in accounts payable and accrued liabilities of $5,631, partially offset by non-cash accrued compensation of $12,000 and $9,694 of Company costs paid directly by our Chief Executive Officer.

Net cash used in operating activities for the six months ended September 30, 2025, was primarily the result of a net loss of $70,553, offset by non-cash items including accrued payroll of $24,000 and $10,820 of Company costs paid directly by our Chief Executive Officer, and changes in working capital related to an increase in prepaid expenses of $4,194 and a decrease in accounts payable and accrued liabilities of $4,927.

Investing Activities

There was no investing activity during each of the six months ended September 30, 2026 and 2025.

Financing Activities

Net cash provided by financing activities was $51,000 for the six months ended September 30, 2026, compared to $44,304 for the six months ended September 30, 2025. During the six months ended September 30, 2026, the Company received $38,500 in unsecured advances from our Chief Executive Officer, who also paid $9,694 of Company costs directly, with no funds repaid to the related party during the period, and a $12,500 advance from an unrelated third party. During the six months ended September 30, 2025, the Company received $46,500 in proceeds from a related party in the form of unsecured advances (in addition to $10,820 of Company costs the related party paid directly) and repaid $2,196 to a related party to reduce unsecured advances payable.

Liquidity and Capital Resources

We are in need of additional cash resources to maintain our operations. As of September 30, 2026, we had cash of $1,866 and prepaid expenses of $16,700. At September 30, 2026 we had a working capital deficit of $1,618,216, comprised of current assets of $18,762 and current liabilities of $1,636,978. Our current liabilities include $796,155 payable to our Chief Executive Officer for accrued compensation and unsecured advances, $764,645 of accrued and unpaid dividends on our Series A and Series B Preferred Stock and a $12,500 advance from a third party. Net cash used in operating activities was $50,636 for the six months ended September 30, 2026 and $44,854 for the six months ended September 30, 2025, funded principally by advances from our Chief Executive Officer.

We are in the early stage of development and have experienced net losses to date and have not generated revenue from operations, which raises substantial doubt about our ability to continue as a going concern. There are a number of conditions that we must satisfy before we will be able to acquire, license and acquire products and intellectual property, not the least of which is negotiating and financing any acquisitions. We are in the process of identifying and establishing strategic partners and technologies in order to establish a market and generate commercial orders by customers and licensing which will include effective marketing and sales capabilities for any products. We do not currently have sufficient resources to accomplish any of these conditions necessary for us to generate revenue and expect to incur increasing operating expenses. We will require substantial additional funds for operations and to fund our business objectives. There can be no assurance that financing, whether debt or equity, will always be available to us in the amount required at any particular time or for any particular period or, if available, that it can be obtained on terms favorable to us. If additional funds are raised by the issuance of equity securities, such as through the issuance and exercise of warrants, then existing stockholders will experience dilution of their ownership interest. If additional funds are raised by the issuance of debt or other equity instruments, we may be subject to certain limitations in our operations, and issuance of such securities may have rights senior to those of the then existing stockholders. We currently have no agreements, arrangements or understandings with any person or entity to obtain funds through bank loans, lines of credit or any other sources.

17

Going Concern

The accompanying condensed consolidated financial statements have been prepared on a going concern basis which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As shown in the condensed consolidated financial statements, the Company has incurred recurring net losses since its inception and has raised limited capital. The Company had a net loss of $52,733 and $70,553 for the six-month periods ended September 30, 2026, and 2025, respectively. The Company's accumulated deficit was $35,716,936 and $35,554,968 as of September 30, 2026, and March 31, 2026, respectively. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or the amounts and classification of liabilities, that might be necessary should the Company be unable to continue as a going concern. The Company is taking certain steps to provide the necessary capital to continue its operations. These steps include but are not limited to: 1) focus on our new business model and 2) raising equity or debt financing.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Critical Accounting Estimates

The financial statements are prepared in accordance with accounting principles generally accepted in the U.S. ("GAAP"). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, costs and expenses and related disclosures. We base our estimates on historical experience, as appropriate, and on various other assumptions that we believe are reasonable under the circumstances. Changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ significantly from the estimates made by our management. We evaluate our estimates and assumptions on an ongoing basis. To the extent that there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. Our significant accounting policies are more fully discussed in Note 2 to our unaudited condensed financial statements contained herein.

Use of Estimates

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the accrual of Series A and Series B preferred dividends, accrued related-party compensation and advances, and the assessment of the Company's ability to continue as a going concern. Actual results could differ from those estimates.

Recent Accounting Pronouncements

In November 2023, the FASB issued Accounting Standards Update ("ASU") 2023-07 - Improvements to Reportable Segment Disclosures, which enhances the disclosures required for reportable segments in annual and interim financial statements, including additional, more detailed information about a reportable segment's expenses. The standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07 for the year ended March 31, 2025, retrospectively to all periods presented in the financial statements. The adoption of this ASU had no impact on reportable segments identified and had no effect on the Company's financial position, results of operations, or cash flows. In December 2023, the FASB issued ASU 2023-09 - Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures. The Company adopted ASU 2023-09 for the year beginning April 1, 2025. The adoption of this ASU had no impact on the Company's financial position, results of operations, or cash flows.

18

Recent Accounting Standards Not Yet Adopted:

In November 2024, the FASB issued ASU 2024-03, - Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). This ASU requires disclosures about specific types of expenses included in the expense captions presented on the face of the statement of operations as well as disclosures about selling expenses. The standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company will evaluate the full extent of the adoption of ASU 2024-03, but believes it will not have a material impact on its consolidated financial statements and disclosures. The Company has also reviewed other recently issued accounting pronouncements and does not believe any such pronouncements will have a material impact on its condensed consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the applicability of Topic 270 and the form and content of interim financial statements. For public business entities, ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company does not expect the adoption of ASU 2025-11 to have a material impact on its condensed consolidated financial statements and related disclosures.

Groove Botanicals Inc. published this content on November 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 12, 2026 at 15:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]